Approved Business Logo
Gift a Tree Reviews Articles FAQs
Login
Precision Meets Performance: Biopharma Group Introduces Gellert CryoDryer 40™ for Advanced Pilot-Scale Freeze Drying

02 December 2025 | Biopharma Group

Precision Meets Performance: Biopharma Group Introduces Gellert CryoDryer 40™ for Advanced Pilot-Scale Freeze Drying

Now available from Biopharma Group the Gellert CryoDryer 40™ is the perfect solution for freeze-drying in pilot and small manufacturing scale environments.

Its combination of capacity, control and automation enables producers to deliver high-quality, shelf-stable products, speed up innovation and scale with confidence. With its large capacity and precise temperature/vacuum control, customers can increase batch sizes without compromising on product structure, nutritional value or performance. Because the CryoDryer 40™ enables pilot-scale testing with production-relevant features, companies developing new products can validate and optimise processes more quickly before investing in full scale, shortening development timelines.

The automation (AutoDry) and process control reduce cycle times, operator intervention and batch-failure risk, thereby lowering cost per unit and increasing manufacturing consistency. Freeze-drying (lyophilisation) preserves structure, flavour, nutrient content and moisture removal more effectively than traditional dehydration providing you with enhanced product quality & increased shelf life.

Future proofing your manufacturing investment, with Biopharma Group support and the scalability of the Gellert range, customers are not locked into one capacity, they can upgrade or scale further as business grows.

For more information on specifications, application suitability, installation, service packages and financing options, please contact the Biopharma Group team of lyophilisation specialists visit: www.biopharmagroup.org

Other Press Releases from Biopharma Group

10/1/2025 - Lyophilization, Liquid Product & Bioprocess Manufacturing Symposium Symposium overview
14/6/2024 - Mastering Oligonucleotide Prep: Why Genevac Solvent Evaporation is Your Secret Weapon Oligonucleotides are revolutionising research and therapeutics, and their success hinges on meticulous sample preparation, whereby solvent evaporation can significantly impact downstream applications.
14/6/2024 - TECNIC appoints Biopharma Group as their new approved distributor for the UK & Ireland TECNIC bioreactors & TFF systems are now exclusively available from Biopharma Group
28/3/2022 - The importance/challenges of mRNA vaccines, and how the correct lyo and fill/finish equipment can support your mRNA ambitions. This article investigates the importance of selecting the correct equipment to support the R&D and scale-up process when considering the challenges associated with the design and manufacture of mRNA vaccines.
15/3/2022 - Advanced HPLC Provides Rapid Screening Method Development of Peptides and Oligonucleotides in Drug & Vaccine Discovery A new era has emerged in HPLC witnessing multiple separation channels merged into single dynamic systems. This approach is now rapidly demonstrating how advantages are not limited to increasing product throughput alone. This article reviews the latest developments of the Sepiatec Sepmatix parallel HPLC system range.